161 related articles for article (PubMed ID: 25043925)
1. Prevalence estimation subject to misclassification: the mis-substitution bias and some remedies.
Zhang Z; Liu C; Kim S; Liu A
Stat Med; 2014 Nov; 33(25):4482-500. PubMed ID: 25043925
[TBL] [Abstract][Full Text] [Related]
2. A pseudo-likelihood method for estimating misclassification probabilities in competing-risks settings when true-event data are partially observed.
Mpofu PB; Bakoyannis G; Yiannoutsos CT; Mwangi AW; Mburu M
Biom J; 2020 Nov; 62(7):1747-1768. PubMed ID: 32520411
[TBL] [Abstract][Full Text] [Related]
3. Prevalence estimation and validation of new instruments in psychiatric research: an application of latent class analysis and sensitivity analysis.
Pence BW; Miller WC; Gaynes BN
Psychol Assess; 2009 Jun; 21(2):235-9. PubMed ID: 19485679
[TBL] [Abstract][Full Text] [Related]
4. Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.
G Thomas E; B Peskoe S; Spiegelman D
Stat Med; 2018 Mar; 37(7):1101-1114. PubMed ID: 29230839
[TBL] [Abstract][Full Text] [Related]
5. Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design.
Molebatsi K; Gabaitiri L; Mokgatlhe L; Moyo S; Gaseitsiwe S; Wirth KE; DeGruttola V; Tchetgen Tchetgen E
Stat Med; 2020 Oct; 39(24):3255-3271. PubMed ID: 32875624
[TBL] [Abstract][Full Text] [Related]
6. Studies of AIDS and HIV surveillance. Screening tests: can we get more by doing less?
Tu XM; Litvak E; Pagano M
Stat Med; 1994 Oct 15-30; 13(19-20):1905-19. PubMed ID: 7846399
[TBL] [Abstract][Full Text] [Related]
7. Nonparametric estimation of the cumulative incidence function under outcome misclassification using external validation data.
Edwards JK; Bakoyannis G; Yiannoutsos CT; Mburu MW; Cole SR
Stat Med; 2019 Dec; 38(29):5512-5527. PubMed ID: 31647581
[TBL] [Abstract][Full Text] [Related]
8. Estimation of odds ratio from group testing data with misclassified exposure.
Roy S; Adhya S; Rana S
Biom J; 2024 Jan; 66(1):e2200254. PubMed ID: 38285402
[TBL] [Abstract][Full Text] [Related]
9. A methodology for deriving the sensitivity of pooled testing, based on viral load progression and pooling dilution.
Nguyen NT; Aprahamian H; Bish EK; Bish DR
J Transl Med; 2019 Aug; 17(1):252. PubMed ID: 31387586
[TBL] [Abstract][Full Text] [Related]
10. Estimating diagnostic accuracy of multiple binary tests with an imperfect reference standard.
Albert PS
Stat Med; 2009 Feb; 28(5):780-97. PubMed ID: 19101935
[TBL] [Abstract][Full Text] [Related]
11. When Does Differential Outcome Misclassification Matter for Estimating Prevalence?
Edwards JK; Cole SR; Shook-Sa BE; Zivich PN; Zhang N; Lesko CR
Epidemiology; 2023 Mar; 34(2):192-200. PubMed ID: 36722801
[TBL] [Abstract][Full Text] [Related]
12. Using interviewer random effects to remove selection bias from HIV prevalence estimates.
McGovern ME; Bärnighausen T; Salomon JA; Canning D
BMC Med Res Methodol; 2015 Feb; 15():8. PubMed ID: 25656226
[TBL] [Abstract][Full Text] [Related]
13. Adjusting age and stage distributions for misclassification errors.
Conn PB; Diefenbach DR
Ecology; 2007 Aug; 88(8):1977-83. PubMed ID: 17824429
[TBL] [Abstract][Full Text] [Related]
14. Efficient logistic regression designs under an imperfect population identifier.
Albert PS; Liu A; Nansel T
Biometrics; 2014 Mar; 70(1):175-84. PubMed ID: 24261471
[TBL] [Abstract][Full Text] [Related]
15. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity.
Buderer NM
Acad Emerg Med; 1996 Sep; 3(9):895-900. PubMed ID: 8870764
[TBL] [Abstract][Full Text] [Related]
16. Bias correction methods for test-negative designs in the presence of misclassification.
Endo A; Funk S; Kucharski AJ
Epidemiol Infect; 2020 Sep; 148():e216. PubMed ID: 32895088
[TBL] [Abstract][Full Text] [Related]
17. Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence.
Chen Y; Wang J; Chubak J; Hubbard RA
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):264-268. PubMed ID: 30375122
[TBL] [Abstract][Full Text] [Related]
18. Estimating incidence rates with misclassified disease status: a likelihood-based approach, with application to hepatitis C virus.
Shebl FM; El-Kamary SS; Shardell M; Langenberg P; Dorgham LS; Maguire JH; Magder LS
Int J Infect Dis; 2012 Jul; 16(7):e527-31. PubMed ID: 22543295
[TBL] [Abstract][Full Text] [Related]
19. Sample size calculation and re-estimation based on the prevalence in a single-arm confirmatory diagnostic accuracy study.
Stark M; Zapf A
Stat Methods Med Res; 2020 Oct; 29(10):2958-2971. PubMed ID: 32299298
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Fang CT; Field SP; Busch MP; Heyns Adu P
Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
